Summary

In a surgery known for substantial blood loss (often >5 L) and need for transfusion, two antifibrinolytics significantly reduced the primary outcomes of intraoperative and total blood loss compared with placebo in patients aged =50 years. However, in patients aged <50 years, no significant differences were seenA.